Navigation Links
Sense of Smell May Be a Vital Clue for Exercise Levels in Parkinson's Disease
Date:5/15/2013

Staten Island, NY (PRWEB) May 15, 2013

Most people with Parkinson’s Disease are unaware that they are losing their sense of smell. However, according to Dr. Ben Weinstock, a local physical therapist, a poor sense of smell could signal something much worse: a loss of nerve cells in the heart. Recent studies have shown that the loss of specific brain cells that process odors has a close correlation with the loss of cardiac neurons in Parkinson’s Disease. "If that loss is severe enough, the additional stress of exercise could lead to a wide range of complications, such as fatigue, fainting, abnormal heart rhythms, even sudden death,” said Dr. Weinstock. “There are numerous benefits of exercise in Parkinson’s. An important aspect of physical therapy is to enhance the exercise experience by minimizing the risks and complications.”

In the United States alone, the financial costs of Parkinson’s Disease run into billions of dollars. With the aging of the population, these numbers are expected to double in coming years. Reducing complications could improve the quality of life for people with the disease, in addition to being be a huge money-saver.

Weinstock, founder of Weinstock Physical Therapy, PC, uses the University of Pennsylvania Smell Identification Test (UPSIT), known commercially as the Smell Identification Test. It has been tested on thousands of patients worldwide and used in hundreds of scientific studies. The results of UPSIT, in conjunction with other tests, gives clues as to how much the heart may be involved in Parkinson’s Disease.

A common misconception about Parkinson’s Disease is that it is only a movement disorder, causing tremor, muscle rigidity, difficulty walking, balance problems, and slowness of movement. Actually, Parkinson’s is almost always preceded by what is known as “non-motor signs,” problems that involve other body systems. These could be constipation, loss of smell, poor sleep, depression, and fatigue. As time progresses, the non-motor problems have to potential to severely impact the quality of life for people with the disease if not detected and treated properly.

Dr. Weinstock has developed an innovative methodology to evaluate and treat patients with Parkinson’s Disease and related disorders called ‘The Parkinson’s Exercise Prescription™’, or PEP. According to Dr. Weinstock, “PEP is a paradigm shift because it integrates research from the growing fields of neurocardiology and autonomic medicine in addition to current physical therapy approaches." Besides the smell identification test, Weinstock checks other aspects of non-motor involvement, which allows for the refinement of exercise levels for each patient with Parkinson’s. "This is absolutely critical as no two patients are alike. One could have severe non-motor problems, but relatively minor motor involvement. Another could be just the opposite. Parkinson’s is an extremely complex disease, and requires a complex physical therapy evaluation. That is why the approach is a ‘prescription’ and not a ‘program’—exercises are personalized for each patient."

Read the full story at http://www.prweb.com/releases/2013/5/prweb10727459.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NTUs sense-ational invention helps underwater vessels navigate with ease
2. Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment
3. The First Patient Treated Using Celsense MRI Cell Tracking Technology
4. Assurance Biosense, Inc. Receives FDA 510(k) Clearance
5. Insect drives robot to track down smells
6. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
7. Medical vital-sign monitoring reduced to the size of a postage stamp
8. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
9. Can You Be Too Old for Acne? Probiotic Action comments on news from The Vitals Blog
10. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
11. New NIST microscope measures nanomagnet property vital to spintronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Genprex, Inc. a biopharmaceutical company focused on ... announced that it has retained ICR Healthcare, a ... and advisory firm, to develop and implement an ... investor relations, public relations and digital communications to ... Genprex and its lead candidate Oncoprex, which is ...
(Date:12/7/2016)... Regen BioPharma Inc. (OTCQB: RGBPP) In a recent ... team of scientists in Guangzhou, China ... of NR2F6 in patients with early cervical cancer correlates with ... cancer tissue as well as in the normal tissue surrounding ... study and the first that I am aware of that ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
Breaking Biology News(10 mins):